Not-for-profit Organizations make a difference in fighting global epidemics

Not-for-profit Organizations make a difference in fighting global epidemics

Developing nations suffer acutely from health epidemics due to lack of resources to adequately combat these epidemics. Many of these epidemics are managed reasonable well in developed nations but with low socioeconomic levels and poor living conditions, coupled with weak health infrastructure, diseases such as enteric and diarrheal diseases and AIDS are still major killers […]

了解更多

2016年11月29日

South Korea: Clinical trial opportunities and advantages

Over the last 10 years, South Korea has increasingly become a global clinical trial (CT) hub and has established itself as one of the leading CT destinations in the Asia region. In 2015, South […]

了解更多

2016年11月19日

India improves processes for clinical trials

New initiatives from the country’s regulator aim to smooth the registration of trials and ensure prospective participants fully understand what will be involved through mandatory AV recording of the consent process. Clinical trial applications in India are taking a step forward, with the approval of a Central Drugs Standard Control Organisation (CDSCO) IT-enabled system from […]

了解更多

2016年11月17日

Health Research and Clinical Trials – Improving Health Care for Everyone

Do you ever wonder how prescription medications make their way to your local pharmacy? Clinical trials and health research play a vital role in maintaining the world population’s health on a r […]

了解更多

2016年11月11日

Streamlined clinical trial requirements in India now in place

Effective 2nd August 2016, the Central Drugs Standard Control Organization (CDSCO) India released new circulars in relation to the conduct of clinical trials. These new circulars have modified […]

了解更多

2016年11月9日

Excellent infrastructure and site quality that attracts global clinical trials to Korea

The rising presence of clinical trials (CT) in the Asia-Pacific region is predominantly driven by the East Asian region which includes China, Japan, Korea, Taiwan and Hong Kong. Over the past decade, Korea has become a global clinical trial hub and is one of the leading clinical trial destinations in the Asian region; with approximately […]

了解更多

2016年11月5日

The electronic CTN form (eCTN)

In Australia, The Therapeutic Goods Administration (TGA) is responsible for the regulation of therapeutic goods (TG) – including medicines, vaccines, medical devices, in-vitro diagnostics and biologicals. They provide oversight over manufacturing, import and export of therapeutic goods, clinical trials (CT) and regulatory approvals processes. Australia is well known for its efficient CT start up timelines; […]

了解更多

2016年11月3日

Clinical Trials for Rotavirus are Critical in Emerging Countries

On a global scale, rotavirus causes over 500,000 deaths in children per year, particularly in emerging countries. Rotavirus is a contagious virus that can cause inflammation of the stomach and […]

了解更多

2016年10月22日

Record-setting metrics for Chinese Phase III Diabetes Study

Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations.  One such example of 乔治临 […]

了解更多

2016年10月20日

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )